CAS 117977-21-6
:Rabeprazol-tioéter
- 1H-Benzimidazole,2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-
- 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
- 2-[((4-(3-Methoxypropoxy)-3-methylpyridine-2-yl)methyl)thio]-1H-benzimidazole
- 2-[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole
- 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole
- 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
- 2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole
- H 295/43
- Rabeprazole-thioether
Rabeprazole Sulfide
CAS:Fórmula:C18H21N3O2SPureza:>98.0%(T)(HPLC)Forma y color:White to Almost white powder to crystalPeso molecular:343.45Rabeprazole Related Compound E (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFórmula:C18H21N3O2SForma y color:White Off-White PowderPeso molecular:343.135452-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole
CAS:Fórmula:C18H21N3O2SPureza:98%Forma y color:SolidPeso molecular:343.44322-{[4-(3-Methoxypropoxy)-3-Methylpyridine-2-yl]Methylthio}-1H-Benzimidazole
CAS:2-{[4-(3-Methoxypropoxy)-3-Methylpyridine-2-yl]Methylthio}-1H-BenzimidazolePureza:98%Peso molecular:343.44g/molRabeprazole EP Impurity B (Rabeprazole Sulfide)
CAS:Fórmula:C18H21N3O2SForma y color:White To Off-White SolidPeso molecular:343.452-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
CAS:Producto controladoForma y color:NeatRabeprazole Sulfide
CAS:Rabeprazole Sulfide (Rabeprazole Related Compound E) is an antiulcer drug in the class of proton pump inhibitors.Fórmula:C18H21N3O2SPureza:99.34% - 99.78%Forma y color:Off-White Crystalline PowderPeso molecular:343.44Rabeprazole Sulfide
CAS:Impurity Rabeprazole EP Impurity B
Applications Rabeprazole Sulfide (Rabeprazole EP Impurity B) is a metabolite of Rabeprazole (R070500).
References Yoshida, T., et al.: Biotech. Lett., 23, 1217 (2001), Miura, M., et al.: Eur. J. Clin. Pharmacol., 62, 113 (2006), Sheridan, R.P., et al.: J. Med. Chem., 50, 3173 (2007), Ren, S., et al.: Arc. Pharm. Res., 31, 406 (2008),Fórmula:C18H21N3O2SForma y color:NeatPeso molecular:343.452-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:343.450012207031252-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
CAS:Rabeprazole is a proton pump inhibitor that is used to treat acid-related disorders such as gastroesophageal reflux disease and peptic ulcers. Rabeprazole inhibits the production of gastric acid by blocking the hydrogen/potassium ATPase that is found in the parietal cells of the stomach. The main mechanism of action for rabeprazole is competitive inhibition of the proton pump, which leads to decreased gastric acid secretion. Rabeprazole can be administered orally or intravenously, with a half-life of about 2 hours. It has been shown to have an effect on human liver cytochrome P450s, but does not affect the activity of recombinant cytochrome P450 3A4 (CYP3A4). In clinical studies, rabeprazole was shown to have no adverse effects on CYP3A4 activity and may even increase it slightly.Fórmula:C18H21N3O2SPureza:Min. 95%Forma y color:White PowderPeso molecular:343.44 g/molRabeprazole-D4 Sulfide
CAS:Producto controladoApplications Rabeprazole-D4 Sulfide is an intermediate in the synthesis of Rabeprazole-d4 (R070492). Rabeprazole-D4 Sulfide is an isotope-labeled analogue of Rabeprazole Sulfide (Rabeprazole EP Impurity B), which is a metabolite of Rabeprazole (R070500).
References Morii, M., and Takeguchi, N.: J. Biol. Chem., 268, 21553 (1993); Yasuda, S., et al.: Int. J. Clin. Pharmacol. Ther., 32, 466 (1994); Cloud, M.L., et al.: Dig. Dis. Sci., 43, 993 (1998)Fórmula:C18D4H17N3O2SForma y color:NeatPeso molecular:347.468











